Evidence map›Paper›PMID 41196423›Full record

ArticleJournal of molecular modeling2025

An investigation of fucoidan as a potential inhibitor against DENV/NS3 proteases through molecular dynamics simulations and DFT studies.

Swaminathan Ramalingam, Anuradha Venkatraman, Sankar Muthumanickam, Boomi Pandi, Syed Ali Mohamed Yacoob, Balajee Ramachandran, Yogananth Nagarajan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Swaminathan RamalingamPG & Research Department of Biotechnology, Mohamed Sathak College of Arts and Science, Sholinganallur, Chennai, 600119, India.
Anuradha VenkatramanPG & Research Department of Biochemistry, Mohamed Sathak College of Arts and Science, Sholinganallur, Chennai, 600119, India.
Sankar MuthumanickamDepartment of Bioinformatics, Alagappa University, Karaikudi, Tamilnadu, India.
Boomi PandiDepartment of Bioinformatics, Alagappa University, Karaikudi, Tamilnadu, India. Pboomi1983@gmail.com.
Syed Ali Mohamed YacoobPG & Research Department of Biotechnology, Mohamed Sathak College of Arts and Science, Sholinganallur, Chennai, 600119, India. syedmicro555@gmail.com.
Balajee RamachandranDepartment of Bioinformatics, Alagappa University, Karaikudi, Tamilnadu, India.
Yogananth NagarajanPG & Research Department of Biotechnology, Mohamed Sathak College of Arts and Science, Sholinganallur, Chennai, 600119, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDengue virus (DENV) is a mosquito-borne disease that spreads in the tropics and subtropics mainly by the Aedes aegypti mosquito, infecting more than 100 million people every year and causing copious deaths every year. As of now, no direct-acting antiviral drugs or vaccines are available to combat DENV. Therefore, the identification of novel small molecules from natural origin becomes inevitable for the management of DENV fever. Here, fucoidan from Padina gymnospora was analyzed for competitive binding within the active site of nonstructural protein NS3 proteases selected as a potential therapeutic target for direct-acting antivirals. METHODOLOGY: The 3D structure of fucoidan was retrieved from Pubchem and molecular targets was fetched from the Protein Data Bank. Molecular docking was performed with Glide module of Schrodinger and molecular dynamics was studied using GROMACS software. Further, density functional theory (DFT) analysis, ADME properties, and BOILED-egg plot analysis were also studied.  RESULTS AND DISCUSSION: The fucoidan compound was docked with the active site of NS3 proteases, showing docking score variation between -6.458 and -7.483 kcal/mol and strong interaction with the catalytic dyad His51, Asp75, and Ser135 amino acids. Furthermore, binding free energy was calculated by using prime MM/GBSA to assess the binding affinity of fucoidan towards the target protein. Moreover, molecular dynamics simulation was performed to evaluate the structural stability of the docked complexes. In addition, the small HOMO-LUMO gap of -0.189 eV given by DFT analysis indicated the structural stability between the ligand and the protein. The fucoidan phytocompound has satisfied all the relevant pharmacokinetic properties and is also highly absorbed by the gastrointestinal tract.

conclusionFrom the overall findings of this study, it is concluded that the fucoidan from Padina gymnospora has effectively blocked the catalytic dyad of NS3 proteases, which could be considered a potent inhibitor to control the DENV multiplication infection.

Indexed as

Antiviral AgentsDengue VirusMolecular Dynamics SimulationPolysaccharidesProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsCatalytic DomainDensity Functional TheoryMolecular Docking SimulationViral ProteasesAntiviral AgentsfucoidanNS3 protease, dengue virusPolysaccharidesProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesADME predictionBinding free energyFucoidanMolecular dockingMolecular dynamics simulationNS3 proteases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.